Korean J Clin Oncol
Chiotis, K
In some embodiments, the formulation or composition has a viscosity of about 40 cP
[1] Dose-escalation studies, such as a 12-week trial on gradual titration, revealed that beginning at lower doses (e.g., 4 mg) and slowly increasing to therapeutic levels significantly reduced the incidence of nausea, vomiting, and diarrhoea
Low-density lipoprotein cholesterol (LDL-C) is well-acknowledged as playing a crucial role in the pathogenesis of CAD, and lowering of plasma LDL-C results in significant reduction in the morbidity and mortality of CAD [72, 73]
Over time, inflammation can weaken the gut barrier, contribute to ulceration, and drive symptoms such as urgency, bleeding, pain, and fatigue